Global Epigallocatechin Gallate (EGCG) Market Size, Share, and COVID-19 Impact Analysis, By Source (Green Tea and Others), By Formulation Type (Powders, Tablets, Liquids, Capsules, and Others), By Indications (Pharmaceuticals, Dietary Supplements, Functional Foods and Beverages, Cosmetics, and Others), By Distribution Channel (Specialty Stores, Online Stores, Supermarkets, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033

Global Epigallocatechin Gallate (EGCG) Market Insights Forecasts to 2033

• The Global Epigallocatechin Gallate (EGCG) Market Size was estimated at USD 1.02 billion in 2023
• The Market Size is expected to grow at a CAGR of around 9.42% from 2023 to 2033
• The Worldwide Epigallocatechin Gallate (EGCG) Market Size is expected to reach USD 2.51 billion by 2033
• Asia Pacific is predicted to grow at the fastest CAGR throughout the projection period

The Global Epigallocatechin Gallate (EGCG) Market Size is Predicted to exceed USD 2.52 Billion By 2033, Growing at a CAGR of 9.42% from 2023 to 2033.

Market Overview

The epigallocatechin gallate (EGCG) market is an industry that produces, distributes, and utilizes EGCG, a natural compound found in green tea, for its antioxidant properties and potential health benefits. The primary active catechin in green tea is epigallocatechin gallate (EGCG), a naturally occurring substance that additionally exists in cranberries, strawberries, blackberries, kiwis, cherries, pears, peaches, apples, avocados, pecans, pistachios, and hazelnuts. EGCG is among the flavonols subgroup and has been associated with health benefits in ailments such as obesity, diabetes, stroke, Parkinson's, and cancer.

Green tea polyphenols are beneficial for metabolic diseases like obesity, type 2 diabetes, cardiovascular disease, non-alcoholic fatty liver disease, and associated comorbidities as they have many advantageous characteristics, such as antioxidation and modulation of several cellular proteins. The most prevalent polyphenol in green tea, epigallocatechin-3-gallate (EGCG), has been estimated to have many metabolic pathways it can target, as well as antioxidant and free radical scavenging properties. Research studies on humans have demonstrated that it possesses anti-obesity, anti-inflammatory, anti-diabetic, anti-arteriosclerotic, and weight-loss capabilities. In contemporary society, the prevalence of metabolic illnesses has been rising globally across all age groups. EGCG is therefore being studied progressively more to address these concerns.

The epigallocatechin gallate market is expanding, owing to rising consumer awareness of the health benefits of green tea extracts and increasing demand for natural and originally sourced ingredients. Green tea contains a polyphenol that has been scientifically shown to have antioxidant qualities, help with weight management, enhance brain function, and perhaps prevent cancer. The demand for EGCG is expected to increase as consumers become more health-conscious, which will further accelerate market growth in the upcoming years.

Report Coverage

This research report categorizes the global epigallocatechin gallate (EGCG) market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyzes the key growth drivers, opportunities, and challenges influencing the global epigallocatechin gallate (EGCG) market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyzes their core competencies in each sub-segment of the global epigallocatechin gallate (EGCG) market.

Driving Factors:

The epigallocatechin gallate (EGCG) market is experiencing significant growth due to the health and wellness trend, with consumers seeking natural ways to enhance their well-being. EGCG, known for its antioxidant and anti-inflammatory properties, is particularly popular in the nutraceuticals and dietary supplements sector. Research into EGCG's therapeutic potentials, such as cancer prevention and cardiovascular health, presents opportunities for pharmaceutical companies. The demand for natural and organic cosmetics is also increasing, with consumers becoming wary of synthetic ingredients in skincare. The beauty and personal care industry can leverage this trend by incorporating EGCG into various products.

Restraining Factors

Variations in the prices of the raw material, stringent regulatory frameworks, the presence of alternatives, and limited awareness of the natural therapies may impede the growth of the market.

Market Segmentation

The global epigallocatechin gallate (EGCG) market share is classified into source, formulation type, indications, and distribution channel.

• The green tea segment dominated the global epigallocatechin gallate (EGCG) market in 2023 and is anticipated to grow at a significant CAGR throughout the forecast period.

Based on the source, the global epigallocatechin gallate (EGCG) market is categorized into green tea and others. Among these, the green tea segment dominated the global epigallocatechin gallate (EGCG) market in 2023 and is anticipated to grow at a significant CAGR throughout the forecast period. The segment growth is attributed to a rich source of the epigallocatechin gallate, enhanced metabolic rate, antioxidants-rich, extensive usage by individuals owing to the presence of polyphenols resulting in the beneficial effects in the management of the chronic diseases such as cardiovascular diseases, diabetes, neurodegenerative disorders, and rising demand of natural supplements.

• The capsules segment accounted for the largest share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe.

Based on the formulation type, the global epigallocatechin gallate (EGCG) market is categorized into powders, tablets, liquids, capsules, and others. Among these, the capsules segment accounted for the largest market share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe. The segmental expansion is owing to patient convenience, ease of administration, greater bioavailability, precise dosing, cost-effectiveness, better taste masking, rapid relief from symptoms, excellent physical and chemical stability, and availability in the controlled drug delivery system.

• The dietary supplements held the largest share in 2023 and is predicted to grow at a significant CAGR throughout the projected timeframe.

Based on the indications, the global epigallocatechin gallate (EGCG) market is categorized as pharmaceuticals, dietary supplements, functional foods and beverages, cosmetics, and others. Among these, the dietary supplements held the largest share in 2023 and is predicted to grow at a significant CAGR throughout the projected timeframe. The segment expansion is facilitated by the provision of essential nutrients such as vitamins and fibers, improvement of overall health, immunity boosters, rising demand for naturally derived dietary supplements owing to the aesthetic living of the individuals, and extensive usage by geriatric populations.

• The online stores segment accounted for the largest share in 2023 and is anticipated to grow at a significant CAGR throughout the projected timeframe.

Based on the distribution channel, the global epigallocatechin gallate (EGCG) market is categorized as specialty stores, online stores, supermarkets, and others. Among these, the online stores segment accounted for the largest share in 2023 and is anticipated to grow at a significant CAGR throughout the projected timeframe. The segment growth is attributed to the personalized recommendations, time saving, increasing trend of the online shopping, availability of the wide range and various brands of the EGCG products, facilities of the reviewing, price comparison, offer discounts, authenticity, and fast shipping,

Regional Segment Analysis of the Global Epigallocatechin Gallate (EGCG) Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the global epigallocatechin gallate (EGCG) market over the predicted timeframe.

North America is anticipated to hold the largest share of the global epigallocatechin gallate (EGCG) market over the predicted timeframe. The focus on health and well-being and increased consumer awareness are driving growth in the EGCG market in North America. Natural and organic items are in high demand, especially functional foods and dietary supplements. The U.S. and Canada, with their existing research infrastructure, are major contributors to industry growth. With new product offerings and growing distribution networks, the market is anticipated to rise gradually. The rising interest of millennials in dietary supplements, well-known producers, and government initiatives to raise national health standards are some of the factors driving this expansion.

Asia Pacific is anticipated to grow at the fastest CAGR throughout the projected timeframe. The Asia Pacific region is seeing tremendous expansion due to the consumption and production of green tea in China, Japan, and India. China is a significant producer of green tea, which supplies the raw ingredients needed to extract EGCG. EGCG-based products are in high demand because of their traditional use in these cultures and growing health consciousness. The growing applications in pharmaceuticals, cosmetics, and nutritional supplements are anticipated to propel the market's growth at a compound annual growth rate (CAGR). The Asia Pacific region's growth prospects are further supported by major market stakeholders and continuing research initiatives.

Competitive Analysis:

The report offers an appropriate analysis of the key organizations/companies involved within the global epigallocatechin gallate (EGCG) market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Blue California
• Indena S.p.A.
• Hunana Nutramax Inc.
• Changsha Organic Herb Inc.
• Wuhan Vanz Pharma Inc.
• Tate and Lyle
• Glentham Life Sciences
• Riotto Botanical
• Yangling Ciyuan Biotech
• DSM Nutritional Products
• Taiyo International
• Xian Greena Biotech Co., Ltd.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In July 2024, Pharmasset Inc., a late-preclinical pharmaceutical development company, received the US FDA approval of Orphan Drug Designation (ODD) for its high-purity, high-potency drug, epigallocatechin gallate (EGCG), a component of green tea being developed for treating inflammatory bowel disease.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global epigallocatechin gallate (EGCG) market based on the below-mentioned segments:

Global Epigallocatechin Gallate (EGCG) Market, By Source

• Green Tea
• Others

Global Epigallocatechin Gallate (EGCG) Market, By Formulation Type

• Powders
• Tablets
• Liquids
• Capsules
• Others

Global Epigallocatechin Gallate (EGCG) Market, By Indications

• Pharmaceuticals
• Dietary Supplements
• Functional Foods and Beverages
• Cosmetics
• Others

Global Epigallocatechin Gallate (EGCG) Market, By Distribution Channel

• Specialty Stores
• Online Stores
• Supermarkets
• Others

Global Epigallocatechin Gallate (EGCG) Market, By Regional

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa